Paper of the Month - May, 2012

0 rating

Receptor changes in metachronous breast tumors – our experience of 10 years.

Bhullar JS, Unawane A, Subhas G et al.
The incidence of clinically observed bilateral breast cancer is reported to range from 1.4% to 11.8%. A recent study reported a decrease in the risk of contralateral breast cancer (CBC) over the last 30 years from approximately 1% per year to 0.2% per year in the current era (J Clin Oncol 2011;29:1564–9). Various studies have shown that the risk of developing a CBC in women diagnosed with breast cancer is 2–7-times greater than the risk of developing a first breast cancer in the general population.


Breast Cancer Poll 1
What approach do you currently use for the treatment of patients with HER2-overexpressing metastatic breast cancer whose disease has progressed despite trastuzumab?

Powered by NetPolls